USP role in strengthening local pharmaceutical …pharmaconnect.co.za/wp-content/uploads/2018/03/Paul-Nkansah-USP... · United States Pharmacopeia ... 7 Levofloxacin API Langhua Pharma
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Evidence for application CHX for prevention of umbilical cord infection and neonatal mortality
4. Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta ZA. Topical application of chlorhexidine to neonatal umbilical cords for prevention of omphalitis and neonatal
mortality in a rural district of Pakistan: a community-based, cluster-randomised trial. Lancet. 2012;379(9820):1029-1036. doi:10.1016/S0140-6736(11)61877-1.
5. Mullany LC, Darmstadt GL, Khatry SK, et al. Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in
southern Nepal: A community-based, cluster-randomised trial. Lancet. 2006;367(9514):910-918. doi:10.1016/S0140-6736(06)68381-5.
6. Arifeen S El, Mullany LC, Shah R, et al. The effect of cord cleansing with chlorhexidine on neonatal mortality in rural Bangladesh: a community-based,
7. Imdad A, Mullany LC, Baqui AH, et al. The effect of umbilical cord cleansing with chlorhexidine on omphalitis and neonatal mortality in community settings
in developing countries: a meta-analysis. BMC Public Health. 2013;13(Suppl 3):S15. doi:10.1186/1471-2458-13-S3-S15.
• 42%(13/31) of manufacturers that underwent GMP audit received technical assistance • Product development based on work done and published by USP/PATH/Lomus Pharma on
chlorhexidine digloconate 7.1% gel
• USP-PQM partnered with PATH, Chlorhexidine, Working Group(CWG), and the UN
The Promoting the Quality of Medicines (PQM) program implemented by the US Pharmacopeia Convention (USP) and PATH are working to establish local and regional manufacturing hubs for chlorhexidine in Asia and Africa
Technology transfer as an enabler of local pharma production and medicines access • Tech Transfer can enable low- and middle-income countries to accelerate the
acquisition of knowledge, experience and equipment related to
pharmaceutical products and processes
• Tech transfer can increase reliability of supply and decrease reliance on
imports, raise competence of local workforce, and reverse “brain drain” from
low- and middle-income countries
• Technology transfer can create positive spillover effects into associated
industries and support public sector research and manufacturing infrastructure
• Transfer of technology is a key component of socio-economic development
• WHA resolution 61.21(2018) on Global Strategy and Plan of Action on Public
Health, Innovation and Intellectual Property focuses on local pharma production
and tech transfer as a means of promoting innovation, building capacity, and